Chemical Compound

Lactosylceramide

CAS Registry Number 4201-62-1
Back to search Request a Quote
Lactosylceramide chemical structure
Primary Record

Lactosylceramide

In stock
7,977 g
Purity
98.3 %
CAS
4201-62-1

Compound Identifiers & Properties

CAS
4201-62-1
PubChem CID
53477895
SMILES
CCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O)[C@@H](/C=C/CCCCCCCCCCCCC)O
Canonical SMILES
CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCC

Names & Synonyms

  • Lactosylceramide
  • LacCer
  • Cytopylin H
  • LacCer(d18:1/16:0)
  • CDw17 antigen
  • C16LacCer
  • C16:0LacCer
  • lactosyl-n-acylsphingosine
  • RefChem:1088319
  • 4201-62-1
  • N-Hexadecanoyl-lactosylceramide
  • orb1694300
  • SCHEMBL9362810
  • CHEBI:84758
  • N-Lignoceryl sphingosyl lactoside
  • LacCer (d18:1/16:0)
  • C46H87NO13
  • Gal-beta1->4Glc-beta1->1'Cer
  • C16 Lactosylceramide (d18:1/16:0)
  • Lactosyl ceramide (d18:1/16:0)
  • MFCD28789016
  • AKOS040754843
  • N-(hexadecanoyl)-1-b-lactosyl-sphing-4-enine
  • D-Galactosyl-1,4-beta-D-glucosylceramide
  • C16 Lactosyl Ceramide (d18:1/16:0)
  • C16 Lactosylceramide (d18:1/16:0))
  • HY-153830
  • J187.534E
  • D-lactosyl-beta-1,1' N-palmitoyl-D-erythro-sphingosine
  • J3.697.092H
  • beta-D-Galactosyl-1,4-beta-D-glucosylceramide
  • c16 lactosyl(beta) ceramide (d18:1/16:0)
  • G91375
  • delta-Galactosyl-1,4-beta-delta-glucosylceramide
  • N-(hexadecanoyl)-1-beta-lactosyl-sphing-4-enine
  • beta-delta-Galactosyl-1,4-beta-delta-glucosramide
  • Beta-delta-Galactosyl-1,4-beta-delta-Glucosylceramide
  • Q27158044
  • N-[(1S,2R,3E)-1-[(4-O-beta-D-Galactopyranosyl-beta-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide
  • 1-O-(4-O-b-D-galactopyranosyl-b-D-glucopyranosyl)-Ceramide
  • 1-O-(4-O-beta-D-Galactopyranosyl-beta-glucopyranosyl)ceramide
  • beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-hexadecanoylsphingosine
  • N-[(E,2S,3R)-1-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]hexadecanamide
  • 1-O-(4-O-beta-delta-Galactopyranosyl-beta-glucopyranosyl)ceramide
  • 1-O-(4-O-beta-delta-galactopyranosyl-beta-delta-glucopyranosyl)-Ceramide
  • 1ylce-O-(4-O-beta-delta-Galactopyranosyl-beta-glucopyranosyl)ceramide
  • N-Hexadecanoyl-1-O-(4-O-beta-D-galactopyranosyl-beta-D-glucopyranosyl)sphingosine
  • (2S,3R,4E)-2-(Hexadecanoylamino)-1-(4-O-beta-D-galactopyranosyl-beta-D-glucopyranosyloxy)-4-octadecen-3-ol
  • [(2S,3R)-2-(Hexadecanoylamino)-3-hydroxy-4-octadecenyl]4-O-beta-D-galactopyranosyl-beta-D-glucopyranoside
  • CDH
  • Hexadecanamide, N-[(1S,2R,3E)-1-[[(4-O-beta-D-galactopyranosyl-beta-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-
  • Hexadecanamide,N-[(1S,2R,3E)-1-[[(4-O-beta-D-galactopyranosyl-beta-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-
  • N-[(2S,3R)-1-{[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide
  • N-[(2S,3R,4E)-1-{[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide
  • N-[(2S,3R,4E)-1-{[4-O-(beta-D-galactopyranosyl)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide
  • N-[(E,1S,2R)-1-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxymethyl]-2-hydroxy-heptadec-3-enyl]hexadecanamide